{"entity":{"type":"insider","cik":"0001873839","url":"/insider/0001873839","json_url":"/insider/0001873839.json","name":"Simpson Adam K.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":7,"first":"2022-08-02","last":"2024-02-02","span_basis":"filed_date"},"name_variants":[{"name":"Simpson Adam K.","source":"filing","n_filings":7,"first_seen":"2022-08-02","last_seen":"2024-02-02"}],"transactions":[{"id":2234836,"accession":"0000950170-24-010798","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-010798","line_url":"/filing/0000950170-24-010798#line-3","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001873839","owner_name":"Simpson Adam K.","owner_display_name":"Simpson Adam K.","owner_url":"/insider/0001873839","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":15.2924,"price_display":"15.29","price_state":"stated","total_value":229386.0,"total_display":"229,386.00","total_whole":"229,386","shares_owned_after":358657.0,"shares_owned_after_display":"358,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-02","scope":"insider"},{"id":2888026,"accession":"0001209191-24-000844","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-000844","line_url":"/filing/0001209191-24-000844#line-2","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001873839","owner_name":"Simpson Adam K.","owner_display_name":"Simpson Adam K.","owner_url":"/insider/0001873839","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":15.6725,"price_display":"15.67","price_state":"stated","total_value":235087.5,"total_display":"235,087.50","total_whole":"235,088","shares_owned_after":260641.0,"shares_owned_after_display":"260,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-02","filed_date":"2024-01-04","scope":"insider"},{"id":8000396,"accession":"0001209191-23-059625","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-059625","line_url":"/filing/0001209191-23-059625","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001873839","owner_name":"Simpson Adam K.","owner_display_name":"Simpson Adam K.","owner_url":"/insider/0001873839","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90000.0,"shares_display":"90,000","price_per_share":15.436444444444444,"price_display":"15.44","price_state":"stated","total_value":1389280.0,"total_display":"1,389,280.00","total_whole":"1,389,280","shares_owned_after":300641.0,"shares_owned_after_display":"300,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-22","scope":"insider","n_lines":2},{"id":8000377,"accession":"0001209191-23-059625","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059625","line_url":"/filing/0001209191-23-059625#line-1","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001873839","owner_name":"Simpson Adam K.","owner_display_name":"Simpson Adam K.","owner_url":"/insider/0001873839","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62205.0,"shares_display":"62,205","price_per_share":15.4571,"price_display":"15.46","price_state":"stated","total_value":961508.9055,"total_display":"961,508.91","total_whole":"961,509","shares_owned_after":184724.0,"shares_owned_after_display":"184,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-20","filed_date":"2023-12-22","scope":"insider"},{"id":8546392,"accession":"0001209191-23-044088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-044088","line_url":"/filing/0001209191-23-044088#line-1","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001873839","owner_name":"Simpson Adam K.","owner_display_name":"Simpson Adam K.","owner_url":"/insider/0001873839","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11788.0,"shares_display":"11,788","price_per_share":8.8615,"price_display":"8.86","price_state":"stated","total_value":104459.362,"total_display":"104,459.36","total_whole":"104,459","shares_owned_after":243930.0,"shares_owned_after_display":"243,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-31","filed_date":"2023-08-01","scope":"insider"},{"id":8677753,"accession":"0001209191-23-009918","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-009918","line_url":"/filing/0001209191-23-009918#line-1","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001873839","owner_name":"Simpson Adam K.","owner_display_name":"Simpson Adam K.","owner_url":"/insider/0001873839","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7506.0,"shares_display":"7,506","price_per_share":10.6926,"price_display":"10.69","price_state":"stated","total_value":80258.6556,"total_display":"80,258.66","total_whole":"80,259","shares_owned_after":245041.0,"shares_owned_after_display":"245,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-15","scope":"insider"},{"id":6677309,"accession":"0001209191-22-062666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062666","line_url":"/filing/0001209191-22-062666#line-1","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001873839","owner_name":"Simpson Adam K.","owner_display_name":"Simpson Adam K.","owner_url":"/insider/0001873839","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66764.0,"shares_display":"66,764","price_per_share":8.963,"price_display":"8.96","price_state":"stated","total_value":598405.732,"total_display":"598,405.73","total_whole":"598,406","shares_owned_after":225105.0,"shares_owned_after_display":"225,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-23","scope":"insider"},{"id":6892980,"accession":"0001209191-22-044025","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-044025","line_url":"/filing/0001209191-22-044025#line-3","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001873839","owner_name":"Simpson Adam K.","owner_display_name":"Simpson Adam K.","owner_url":"/insider/0001873839","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1904.0,"shares_display":"1,904","price_per_share":6.7038,"price_display":"6.70","price_state":"stated","total_value":12764.0352,"total_display":"12,764.04","total_whole":"12,764","shares_owned_after":291869.0,"shares_owned_after_display":"291,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-02","filed_date":"2022-08-02","scope":"insider"},{"id":6892976,"accession":"0001209191-22-044025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-044025","line_url":"/filing/0001209191-22-044025#line-2","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001873839","owner_name":"Simpson Adam K.","owner_display_name":"Simpson Adam K.","owner_url":"/insider/0001873839","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7017.0,"shares_display":"7,017","price_per_share":6.6374,"price_display":"6.64","price_state":"stated","total_value":46574.6358,"total_display":"46,574.64","total_whole":"46,575","shares_owned_after":293772.0,"shares_owned_after_display":"293,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-02","scope":"insider"},{"id":6892971,"accession":"0001209191-22-044025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044025","line_url":"/filing/0001209191-22-044025#line-1","is_derivative":false,"issuer_cik":"0001786255","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001786255","owner_cik":"0001873839","owner_name":"Simpson Adam K.","owner_display_name":"Simpson Adam K.","owner_url":"/insider/0001873839","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2456.0,"shares_display":"2,456","price_per_share":7.1076,"price_display":"7.11","price_state":"stated","total_value":17456.2656,"total_display":"17,456.27","total_whole":"17,456","shares_owned_after":300789.0,"shares_owned_after_display":"300,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-29","filed_date":"2022-08-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001786255","name":"Icosavax, Inc.","url":"/issuer/0001786255","role":"Director, Officer (Chief Executive Officer)","n_filings":7,"first_seen":"2022-08-02","last_seen":"2024-02-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001873839","retrieved_at":"2026-08-25T06:14:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}